Ustyol, L. Et Al. 2017. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.36, no.6 , 547-553.

Ustyol, L., Bulut, M. D., Agengin, K., Bala, K. A., Yavuz, A., Bora, A., ... Demiroren, K.(2017). Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.36, no.6, 547-553.

Ustyol, L. Et Al. "Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.36, no.6, 547-553, 2017

Ustyol, L. Et Al. "Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.36, no.6, pp.547-553, 2017

Ustyol, L. Et Al. (2017) . "Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.36, no.6, pp.547-553.

@article{article, author={L. Ustyol Et Al. }, title={Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children}, journal={HUMAN & EXPERIMENTAL TOXICOLOGY}, year=2017, pages={547-553} }